XML 63 R51.htm IDEA: XBRL DOCUMENT v3.20.2
SHARE-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Aug. 02, 2020
Jul. 28, 2019
Aug. 02, 2020
Jul. 28, 2019
Share-based Compensation [Abstract]        
Maximum number of shares of common stock that may be issued (in shares) 4,000,000   4,000,000  
Share-based compensation expense incurred $ 1,200 $ 900 $ 3,800 $ 2,900
Share-based compensation cost capitalized 0 0 0 0
Income tax benefits realized from stock option exercises 0 0 $ 0 $ 0
Restricted Stock [Member]        
Additional disclosures [Abstract]        
Period for recognition of compensation cost not yet recognized     2 years 10 months 24 days  
Restricted Stock [Abstract]        
Restricted stock awards granted (in shares)     527,000 435,000
Weighted average grant date fair value of restricted stock awards (in dollars per share)     $ 15.21 $ 9.80
Compensation cost not yet recognized related to unvested restricted stock awards $ 7,900   $ 7,900  
Number of shares of restricted stock outstanding (in shares) 838,616   838,616  
Restricted Stock [Member] | Minimum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     1 year  
Restricted Stock [Member] | Maximum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     4 years  
Stock Options [Member]        
Share-based Compensation [Abstract]        
Cash received from option exercises $ 300 $ 200 $ 3,500 $ 1,000
Contractual term     10 years  
Additional disclosures [Abstract]        
Share options granted (in shares)   0 0 132,000
Weighted-average grant date fair value of options granted (in dollars per share)       $ 3.31
Unrecognized compensation cost related to unvested option awards $ 500   $ 500  
Period for recognition of compensation cost not yet recognized     1 year 10 months 24 days  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Volatility       33.10%
Dividend yield       0.00%
Expected term       5 years 1 month 6 days
Outstanding and exercisable option awards [Roll Forward]        
Outstanding at end of period (in shares) 1,674,582   1,674,582  
Exercisable at end of period (in shares) 1,402,704   1,402,704  
Weighted-Average Exercise Price [Abstract]        
Weighted average exercise price, Outstanding at end of period (in dollars per share) $ 9.22   $ 9.22  
Weighted average exercise price, Exercisable at end of period (in dollars per share) $ 9.15   $ 9.15  
Weighted-Average Remaining Contractual Life [Abstract]        
Weighted average remaining contractual life, Outstanding at end of period     4 years 10 months 24 days  
Weighted average remaining contractual life, Exercisable at end of period     4 years 4 months 24 days  
Aggregate Intrinsic Value [Abstract]        
Aggregate intrinsic value, Outstanding at end of period $ 4,523   $ 4,523  
Aggregate intrinsic value, Exercisable at end of period $ 3,909   $ 3,909  
Stock Options [Member] | Minimum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     1 year  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Risk free rate of return       2.50%
Stock Options [Member] | Maximum [Member]        
Share-based Compensation [Abstract]        
Award vesting period     4 years  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]        
Risk free rate of return       2.90%